Johnson & Johnson will submit the data to the Food and Drug Administration, which is evaluating similar data on boosters from Pfizer and Moderna. View original article Contributor: Carl Zimmer
Irisin, a hormone produced by muscles during exercise, can enter the brain and improve cognition, a mouse study suggests. View original article Contributor: Gretchen Reynolds
Integrative medicine and MS Norton Healthcare >View original article Contributor:
Welcome to COVID Questions, TIME’s advice column. We’re trying to make living through the pandemic a little easier, with expert-backed answers to your toughest coronavirus-related dilemmas. While we can’t and don’t offer medical advice—those questions should go to your doctor—we hope this column will help you sort through this stressful and confusing time. Got a … Read more
Popular at-home COVID-19 tests from Abbott Laboratories and Quidel Corp., available without a prescription, were launched without a mechanism for reporting results to health officials, potentially leaving many cases uncounted by authorities as the delta variant spreads around the U.S. How many of the products have been sold in pharmacies and online and used isn’t … Read more
Across the U.S. children are heading back to school, despite spiking COVID-19 cases. The emergence of the more contagious Delta variant as the most prominent virus strain in the country is causing concern for parents. Not only are they worried about the health and safety of their kids, they have been dealing with a childcare … Read more
The pandemic is straining the nation’s already stretched health-care system, but there are differences in the suffering. View original article Contributor: Akilah Johnson
Protection against milder infections has waned as the more contagious variant surges. View original article Contributor: Joel Achenbach
A study that followed essential workers in six states found that vaccine protection dropped from 91 percent to 66 percent, still “a really high number,” one scientist said. View original article Contributor: Roni Caryn Rabin
The bank’s announcement comes after the Food and Drug Administration gave full approval for the Pfizer-BioNTech coronavirus shots. View original article Contributor: Lauren Hirsch